Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating Expenses:    
Research and development $ 484,750 $ 821,388
General and administrative 397,766 470,228
Operating Loss (882,516) (1,291,616)
Other Income (Expense):    
Interest expense (4,600) (87,740)
Interest income 5,985 1,024
Net Operating Loss Before Income Tax Benefit (881,131) (1,378,332)
Income Tax Benefit 130,299 281,534
Net Loss $ (750,832) $ (1,096,798)
Net Loss Per Common Share - Basic and Diluted $ (0.02) $ (0.03)
Weighted Average Common Shares Used to Compute Net Loss Per Common Shares - Basic and Diluted 38,674,265 35,272,626